Seeking Alpha

Pfizer (PFE) and Merck (MRK) have recently set up joint ventures to access the mainland market's...

Pfizer (PFE) and Merck (MRK) have recently set up joint ventures to access the mainland market's generic drug sector, but with slightly different agendas. Pfizer has aligned with China's Zhejiang Hisun Pharmaceutical, with the intent to capitalize on its global purchasing network to improve the export quality of generic drugs produced in China. Merck, on the other hand, has aligned itself with China's Simcere Pharmaceutical Group, and is focusing on lowering overall drug costs and deeper penetration of the Chinese market.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|